Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic

The WHO 2020 global TB Report estimates that in 2019 there were an estimated 500,000 cases of multi-drug resistant TB (MDR-TB) of which only 186,772 MDR-TB cases were diagnosed, and positive treatment outcomes were achieved in 57% of them. These data highlight the need for accelerating and improving...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Infect Dis
Main Authors: Tiberi, Simon, Vjecha, Michael J., Zumla, Adam, Galvin, Jessica, Migliori, Giovanni Battista, Zumla, Alimuddin
Formato: Artigo
Idioma:Inglês
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944856/
https://ncbi.nlm.nih.gov/pubmed/33713815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2021.02.067
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares